Skip to content

Schrodinger

US · SDGR #2667 by market cap Listed 2020
22.93 -3.41 -12.95%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Valuation each multiple against its own 5-year range

P/B ratio 7.35 Expensive vs history 99th percentile
5-year average 3.84 · #33 of 37 in Health Information Services
P/E ratio -37.38 Cheap vs history 2nd percentile
5-year average 12.14 · forward -15.59
P/S ratio 8.24 In line with history 45th percentile
5-year average 9.44 · forward 9.43 · #32 of 41 in Health Information Services

Vs. peers Health Information Services

Company Market cap P/E (TTM) P/B Div yield
Schrodinger (SDGR) 1.72B -29.03 5.70 0.00%
Veeva Systems (VEEV) 43.10B 43.64 5.80 0.00%
BrightSpring Health Services (BTSG) 12.50B 33.78 5.75 0.00%
Tempus AI (TEM) 9.86B -50.98 19.70 0.00%
Hinge Health (HNGE) 8.60B 51.68 28.71 0.00%
HealthEquity (HQY) 7.84B 34.21 3.94 0.00%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value33.22 Economic moatNone UncertaintyVery High

Trading 44.9% below Morningstar's fair value estimate.

Fair value

Schrodinger Inc is assigned a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 11% discount to our quantitative fair value estimate of $33.22 per share; however, caution is warranted due to this estimate's very high uncertainty rating.

We need more explanatory data to elaborate on this stock's star rating. We strive to explain the factors driving every rating we assign; however, this is not yet possible for a small fraction of our coverage universe.

Economic moat

With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Schrodinger discussion 0 comments

Add a comment